Cumberland Pharmaceuticals Inc SEC filings CPIX

Cumberland Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Mar 18, 2009. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Mar 12, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Cumberland Pharmaceuticals Inc SEC filings
Form Description Filed Period
ARS Annual report to shareholders Mar 12, 2026 Mar 12, 2026
10-K Annual report Mar 9, 2026 Dec 31, 2025
ARS Annual report to shareholders Mar 18, 2025 Mar 18, 2025
10-K Annual report Mar 7, 2025 Dec 31, 2024
ARS Annual report to shareholders Mar 22, 2024 Dec 31, 2023
10-K Annual report Mar 13, 2024 Dec 31, 2023
ARS Annual report to shareholders Mar 22, 2023 Mar 22, 2023
10-K Annual report Mar 13, 2023 Dec 31, 2022
10-K Annual report Mar 11, 2022 Dec 31, 2021
10-K Annual report Mar 12, 2021 Dec 31, 2020
10-K Annual report Mar 20, 2020 Dec 31, 2019
10-K Annual report Mar 12, 2019 Dec 31, 2018
10-K Annual report Mar 9, 2018 Dec 31, 2017
10-K Annual report Mar 13, 2017 Dec 31, 2016
10-K Annual report Mar 14, 2016 Dec 31, 2015
10-K Annual report Mar 9, 2015 Dec 31, 2014
10-K Annual report Mar 11, 2014 Dec 31, 2013
10-K Annual report Mar 12, 2013 Dec 31, 2012
10-K Annual report Mar 7, 2012 Dec 31, 2011
10-K Annual report Mar 11, 2011 Dec 31, 2010
10-K Annual report Mar 19, 2010 Dec 31, 2009

Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CPIX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TN
Headquarters
Nashville,, TN
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1087294

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.